Evidence map›Paper›PMID 22558468›Full record

ArticlePloS one2012

Determining the repertoire of immunodominant proteins via whole-genome amplification of intracellular pathogens.

Michael J Dark, Anna M Lundgren, Anthony F Barbet

Abstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. First Whole Genome Sequence ofPathogens (Basel, Switzerland) · 2020
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael J DarkDepartment of Infectious Diseases and Pathology, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA. darkmich@ufl.edu
Anna M Lundgren
Anthony F Barbet

Funding

UF Clinical and Translational Science AwardUL1TR000064 · NCATS · UNIVERSITY OF FLORIDA · PI NELSON, DAVID R · 2012 to 2014
$12.2M
Evolution of chronic infection in Anasplasma phagocytophilumR01GM081714 · NIGMS · UNIVERSITY OF FLORIDA · PI BARBET, ANTHONY F. · 2007 to 2010
$1.7M
NCATS NIH HHS UL1 TR000064NIGMS NIH HHS R01 GM081714NIGMS NIH HHS R01GM081714
6 · The paper itself

Abstract

Culturing many obligate intracellular bacteria is difficult or impossible. However, these organisms have numerous adaptations allowing for infection persistence and immune system evasion, making them some of the most interesting to study. Recent advancements in genome sequencing, pyrosequencing and Phi29 amplification, have allowed for examination of whole-genome sequences of intracellular bacteria without culture. We have applied both techniques to the model obligate intracellular pathogen Anaplasma marginale and the human pathogen Anaplasma phagocytophilum, in order to examine the ability of phi29 amplification to determine the sequence of genes allowing for immune system evasion and long-term persistence in the host. When compared to traditional pyrosequencing, phi29-mediated genome amplification had similar genome coverage, with no additional gaps in coverage. Additionally, all msp2 functional pseudogenes from two strains of A. marginale were detected and extracted from the phi29-amplified genomes, highlighting its utility in determining the full complement of genes involved in immune evasion.

Indexed as

Amino Acid SequenceAnaplasma marginaleAnaplasma phagocytophilumAnimalsAntigens, BacterialBacillus PhagesBacterial Outer Membrane ProteinsBacterial ProteinsBase SequenceCattleGenomicsHL-60 CellsHumansIntracellular SpaceMolecular Sequence DataNucleic Acid Amplification TechniquesAntigens, BacterialBacterial Outer Membrane ProteinsBacterial Proteinsmsp2 protein, Anaplasma marginale

Identifiers

PMID22558468
PMCPMC3340345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.